Skip to Content

SZ 327 (Mycophenolate Mofetil 500 mg)

Pill with imprint SZ 327 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; cogan's syndrome; bullous pemphigoid (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for SZ 327

Mycophenolate mofetil 500 mg SZ 327

Mycophenolate Mofetil

Imprint:
SZ 327
Strength:
500 mg
Color:
Purple
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
hypromelloses
ferrosoferric oxide
ferric oxide red
magnesium stearate
microcrystalline cellulose
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0801 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide